- Report
- August 2025
- 197 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- July 2025
- 262 Pages
Global
From €4410EUR$4,950USD£3,837GBP
- Report
- March 2025
- 200 Pages
Global
From €4000EUR$4,490USD£3,480GBP
- Report
- August 2025
- 198 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- April 2025
- 175 Pages
Global
From €4000EUR$4,490USD£3,480GBP
- Report
- October 2025
- 190 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- August 2025
- 190 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- August 2025
- 186 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- May 2024
- 185 Pages
Global
From €4009EUR$4,500USD£3,488GBP
- Report
- October 2024
- 106 Pages
Global
From €3500EUR$4,209USD£3,152GBP
The Hemostatic Sponge market is a segment of the Wound Care industry that focuses on the use of sponges to control bleeding. Hemostatic sponges are designed to absorb blood and form a clot, helping to reduce the risk of infection and promote healing. These sponges are often used in surgical procedures, trauma care, and other medical applications.
Hemostatic sponges are typically made from a combination of natural and synthetic materials, such as collagen, chitosan, and polysaccharides. They are available in a variety of sizes and shapes, and can be used in a variety of medical settings.
The Hemostatic Sponge market is highly competitive, with a number of companies offering products that are designed to meet the needs of healthcare professionals. Some of the leading companies in the market include Johnson & Johnson, Baxter, Medtronic, and Smith & Nephew. Show Less Read more